Role of N-glucuronidation in benzidine-induced bladder cancer in dog

Area of Science:

• Toxicology
• Carcinogenesis
• Metabolism

Background:

• Benzidine is a known carcinogen.
• The mechanism of benzidine-induced bladder cancer in dogs is not fully understood.
• Species-specific differences in benzidine carcinogenesis exist.

Purpose of the Study:

• To investigate the metabolic pathway of benzidine in dogs.
• To identify the key metabolite responsible for benzidine-induced bladder cancer.
• To elucidate the role of liver metabolism in the species specificity of benzidine carcinogenesis.

Main Methods:

• Incubation of [3H]benzidine with dog liver slices and microsomes.
• Analysis of metabolites using Thermospray Mass Spectrometry (MS).
• Stability studies of the identified metabolite in various biological fluids and solvents.

Main Results:

• Dog liver microsomes produced a major metabolite, identified as benzidine N-glucuronide.
• This metabolite was stable in plasma and alkaline urine but degraded rapidly in acidic urine.
• Rat liver microsomes showed minimal activity, suggesting species-specific metabolism.

Conclusions:

• Liver N-glucuronidation of benzidine facilitates its accumulation in acidic urine.
• This accumulation promotes uptake into bladder epithelium and subsequent activation, leading to bladder cancer.
• Liver metabolism and N-glucuronidation are critical factors in the species-specific carcinogenicity of benzidine.